Intrinsic tumor subtypes, defined by a panel of IHC markers (ER, PR, HER2, CK5, CK6, EGFR), identified 51% luminal A, 16% luminal B, 21% basal-like, 6% HER2+/HR-, and 6% unclassified. Here, EGFR is linked to neoplasm.